echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > A novel adamantane-type PPAP pain relief molecule with significant Cav3.2 T-type calcium channel inhibition

    A novel adamantane-type PPAP pain relief molecule with significant Cav3.2 T-type calcium channel inhibition

    • Last Update: 2023-01-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
      

    Polycyclic polyprenylated acylphloroglucinol (PPAP) is a class of natural products with heterozygotic pathways, mainly including bridge ring type, adamantane type and further cracking ring due to the above two architecture types, Rearrangement and sidechain looping of its precursors results in a variety of structurally diverse derivative structure types
    .
    Among them, adamantane
    PPAP has long attracted extensive attention from organic chemists and pharmacocologists due to its rigid cage-like structure and molecular framework of drugs, but its activity research lacks new highlights
    .
    The National Key Experiment on the Structure and Function of Natural Products such as Natural P PAP and Diterpene has long been committed to the study of the structure and function of natural P PAP in Kunming, Chinese Academy of Sciences.
    In recent years, through cooperation with the membrane protein (ion channel) natural medicine research group, a series of p-PAP molecules with p-ring and heteroterpene
    types have significant ion channel activity, and a number of high-level articles have been published (J.
    Med.
    Chem.
    2020, 63, 1709; Org.
    Lett.
    2020, 22, 6339-6343; Tetrahedron Lett.
    2019, 60, 151220), indicating the great potential of P PAP molecules in ion channel activity, and prompting the research team to further try and explore
    the ion channel activity of adamantane P PAP molecules.
     

    In the in-depth study of the ion channel activity of amantadine-type P PAP, the research team found that the two molecules had a significant inhibitory effect on the Cav3.
    2 T-type calcium channel, an important target for pain and epilepsy drug development, and a toxic target for the heart at high doses hERG has no obvious effect
    .
    Among them, compound
    1 is a novel adamantane-type P PAP with a novel octahydro-2,5-methanoindene parent nucleus, and its cyclic pathway was analyzed by biogenic pathway with that of conventional adamantane PPAP ( C-7 isoprene group is very different from the C-3 cyclization of the resorcinol parent nucleus and should be derived from C-7 of the bridge ring PPAP The C-4 position of the isoprene group and the resorcinol parent nucleus are cyclized; Its planar structure and absolute configuration were determined by combining spectral data with quantum chemistry calculations (NMR, ECD calculation and DP4+ analysis
    ).
    It is worth pointing out that compound
    2 has a better inhibitory effect on Cav 3.
    2
    and Cav3.
    1 Cav3.
    3.
    It has obvious selectivity
    .
    In addition, in vivo studies have shown that
    2 can significantly inhibit the mouse twisting reaction induced by acetic acid and prolong the time of the first twisting reaction in mice, and its effect is comparable to
    that of Z 944, a T-type calcium channel inhibitor currently in clinical trials.
    In summary, this study not only discovered a novel type of adamant-type
    P PAP, but also revealed for the first time that adamantane PPAP has a significant inhibitory effect on Ca v 3.
    2.
    It also provides a new structural template
    for the subsequent development of novel painkillers.
     

     

     

    Figure 1: Structure of compounds 1 and 2 and their inhibitory effect on Cav3.
    2
    T-type calcium channels 

    The results end with Cagedpolycyclic polyprenylated acylphloroglucinols as CAv3.
    2 low voltage-gatedCa 2+Channel Inhibitors from Hypericum curvisepalum was published in NatureIndex Journal ChemicalCommunications (DOI: 10.
    1039/D2CC05396A.

    。 Ye Yansong, postdoctoral fellow at Kunming Institute of Botany, Chinese Academy of Sciences, master student Liu Rui and PhD Nana Jiang are co-first authors of the paper, and Xu Gang, researcher and associate researcher Nian Yin of Kunming Institute of Botany, Chinese Academy of Sciences, are co-corresponding authors
    of the paper.
    The research was supported
    by the NSFC-Yunnan Provincial Joint Fund (U1902213), the Western Light Intersection Team and Young Scholars Program of the Chinese Academy of Sciences, and the Yunnan Postdoctoral Targeted Training Grant.

     

    Article link

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.